SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SRDX - SurModics - Biotech IPO
SRDX 28.12+2.5%9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Donald carlson who wrote (4)4/28/1998 10:55:00 AM
From: Will Preska  Read Replies (2) of 84
 
Interesting thoughts on the reason behind the IPO. Sounds plausible to me. I too like to thought of the solid royalty income stream.

My opinion? I wasn't expecting much this soon after the IPO, so the recent earnings results were a nice surprise. I'm thinking that later this year is when we'll see even more of a ramp-up in both revenue and earnings - both in the 30% range. Increased margin, as you suggest, would be great though, so maybe the earnings growth will be more like 35 to 40%. We'll see.

Were your comments (of 30% revs & 30+ earnings growth) based on a particular time frame? How do you feel about SRDX over the next 1yr/2yrs/5yrs?

- Will
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext